NCT07048717

Brief Summary

Mauritius is located in the southern Indian Ocean with a population of 1.3 million in 2023. Mauritius is a multiethnic nation with 68% South Asian, 27% African (Creole), 3% Chinese and 2% Franco Mauritians. Seven population-based cross-sectional surveys using standardised protocols were conducted between 1987 and 2021). The participation rate has been over 85% in each survey. At each survey, participants were interviewed about living conditions, lifestyle and health, and anthropometry and blood pressure were measured. Biochemistry including lipids and an oral glucose tolerance test (OGTT) were performed Electrocardiograms (ECG) were recorded in participants aged 35 years and older. Previous participants were followed up in 2007 and 92% were successfully traced. Studies with identical methodology have been performed on the neighbouring island Rodrigues where the majority of the population are Creoles.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39,082

participants targeted

Target at P75+ for all trials

Timeline
300mo left

Started Apr 1987

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Apr 1987Dec 2050

Study Start

First participant enrolled

April 5, 1987

Completed
34.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 23, 2021

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

June 24, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
25.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2050

Expected
Last Updated

July 17, 2025

Status Verified

July 1, 2025

Enrollment Period

34.7 years

First QC Date

June 24, 2025

Last Update Submit

July 11, 2025

Conditions

Keywords

EpidemiologyCross-sectional studiesPrevalenceIncidenceDiabetes mellitusCardiovascular Disease

Outcome Measures

Primary Outcomes (1)

  • Mortality

    According to household interviews, death certificates from central registers at Ministry of Health and Wellness. 1. Household interviews: "Is the participant alive? If dead, do you have a copy of the death certificate? When did the participant die?" 2. Central registers: Vital status, if dead, date and cause of death from death certificates" Combining 1 and 2 will give date and cause of death. Absolute numbers and mortality rates will be reported for all and in subgroups i.e. sex, age-strata, ethnicity.

    Up to 20 years from the baseline survey

Secondary Outcomes (4)

  • Diabetes Mellitus

    Up to 20 years from the baseline survey

  • Cardiovascular disease (CVD)

    Up to 20 years from the baseline survey

  • Hypertension

    Up to 20 years from the baseline survey

  • Obesity

    Up to 20 years from the baseline survey

Study Arms (2)

Randomly selected population-based subjects from the population (Mauritius)

Seven cross-sectional studies were performed between 1987 and 2021 on mainland Mauritius

Randomly selected population-based subjects from the population (Rodrigues)

In parallell, six cross-sectional studies were performed between 1992 and 2022 on Rodrigues

Eligibility Criteria

Age25 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Random samples from the Mauritian (including Rodrigues) aged 25 to 74 years

You may qualify if:

  • Men and women
  • Randomly selected population-based samples (details see below)
  • Not living in the study area
  • Age outside the age-range
  • In detail:
  • In 2004, a new study was performed, with similar methodology. In 2009, nine index clusters were chosen with one randomly selected from each of the nine districts in Mauritius. Then, two neighbouring clusters were chosen surrounding the index cluster to form a "super cluster." From this super cluster, one in three households was randomly selected and one adult per household was invited to participate.5 The same methodology was used in 2015 and in 2021 with new randomly chosen clusters forming "super cluster" as in 2009. In addition, a random sample from the 1998 survey was invited for a resurvey in 2015.
  • Participation rate has been over 85% in each survey. No sampling weights were used.
  • Same methodology was used in Rodrigues.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Port Louis, Mauritius

Location

Related Publications (1)

  • Soderberg S, Taki H, Kowlessur S, Shaw JE, Magliano DJ, Tamosiunas A, Alberti G, Zimmet P, Tuomilehto J. Trends in the prevalence of cardiovascular disease, defined as ECG abnormalities and/or self-reported events, in Mauritius between 1987 and 2021: analysis of data from seven large population-based surveys. BMJ Open. 2025 Jun 16;15(6):e087693. doi: 10.1136/bmjopen-2024-087693.

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma samples from the last surveys (2021 an 2022) are stored locally in Mauritius

MeSH Terms

Conditions

Diabetes MellitusHypertensionObesityOverweightCardiovascular Diseases

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Paul Zimmet, Professor

    Monash University

    PRINCIPAL INVESTIGATOR
  • George Alberti, Professor

    Imperial College, London, UK

    PRINCIPAL INVESTIGATOR
  • Jaakko Tuomilehto, Professor

    Helsinki University, Helsinki, Finland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
20 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, consultant

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 2, 2025

Study Start

April 5, 1987

Primary Completion

November 23, 2021

Study Completion (Estimated)

December 31, 2050

Last Updated

July 17, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

If you would like to use the data from the Mauritius study, you should contact the Section of Biobank and Registry Support (BRS) at Umeå University, Sweden for discussion: info.brs@umu.se. Before sharing of data, the application will be evaluated by senior researchers within the network. Ethical approval must be obtained.

Shared Documents
STUDY PROTOCOL
Time Frame
Available now
Access Criteria
Reasonable request approved by senior researchers within the study group, plus obtained ethical approval.
More information

Available IPD Datasets

General information about the study plus information about application for data Access

Locations